X0306 4 2015-10-01 0 0001338042 Aegerion Pharmaceuticals, Inc. AEGR 0001653133 Harshbarger Benjamin C/O AEGERION PHARMACEUTICALS, INC. ONE MAIN STREET, SUITE 800 CAMBRIDGE MA 02142 0 1 0 0 General Counsel and Secretary Stock Option (right to buy) 13.19 2015-10-01 4 A 0 30000 0.00 A 2025-10-01 Common Stock 30000 30000 D The stock option award has an exercise price equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant. 25% of the shares of common stock underlying this stock option award will vest on October 1, 2016. The remaining 75% of the shares of common stock underlying this stock option award will vest thereafter in equal monthly installments through October 1, 2019, subject to the Reporting Person's continued employment with the Issuer. /s/ Jennifer Fitzpatrick, attorney-in-fact 2015-10-05